No Right to Purchase. The issuance of the Common Stock, Warrants or Underlying Common Stock in the Offering will not give any holder of any of the Company's outstanding shares of Common Stock, options, warrants or other convertible securities or rights to purchase securities of the Company (i) the right to purchase any additional shares of Common Stock or any other securities of the Company, or (ii) the right to purchase any securities at a reduced price.
No Right to Purchase. The issuance of the Units in the Offering and the Placement Agent Options and the Common Stock upon exercise of the Warrants, the Placement Agent Options and the Warrants issuable thereunder will not give any holder of any of the Company's outstanding shares of Common Stock, options, warrants or other convertible securities or rights to purchase securities of the Company (i) the right to purchase any additional shares of Common Stock or any other securities of the Company, or (ii) the right to purchase any securities at a reduced price.
No Right to Purchase. The issuance of the Units in the Offering will not give any holder of any of the Company's outstanding shares of Common Stock, options, warrants or other convertible securities or rights to purchase securities of the Company (i) the right to purchase any additional shares of Common Stock or any other securities of the Company, or (ii) the right to purchase any securities at a reduced price.
No Right to Purchase. The issuance of the Units in the Offering, the Placement Agent Options and the shares of Common Stock upon conversion of the Debentures and exercise of the Warrants and Placement Agent Options will not give any holder of any of the Company's outstanding shares of Common Stock, options, warrants or other convertible securities or rights to purchase securities of the Company (i) the right to purchase any additional shares of Common Stock or any other securities of the Company, or (ii) the right to purchase any securities at a reduced price, except that if all of the Debentures were converted and all of the Warrants exercised, the number of shares issuable upon conversion of each share of the Company's Series A-2 Preferred Stock would be increased to 13.228 from 12.9053 and the number of shares issuable upon exercise of each of the Company's outstanding warrants issued in connection with the issuance of the Series A-2 Preferred Stock would be increased to 1.35 from 1.29.
No Right to Purchase the Consulting Business or the 3.27 Purchased Assets............................................ 28 3.28
No Right to Purchase. Nothing contained in this Agreement shall be construed as obligating Bear Xxxxxxx to sell the Loans (other than pursuant to the Company's exercise of the Call Option) to the Company or as restricting in any manner the right of Bear Xxxxxxx to sell or assign its interest therein in whole or in part.
No Right to Purchase. Except for the reduction in the maximum conversion price of the Series C Convertible Preferred Stock from $7.08 per share to approximately $5.55 per share, the issuance of the Units or underlying Shares and Warrants in the Offering and upon exercise of the Placement Agent's Purchase Option will not give any holder of any of the Company's outstanding shares of Common Stock, options, warrants or other convertible securities or rights to purchase securities of the Company (i) the right to purchase any additional shares of Common Stock or any other securities of the Company, or (ii) the right to purchase any securities at a reduced price.
